Preparation, stability studies and pharmacological behavior of [186Re]Re-HEDP

99mTc-HEDP is widely used as a bone imaging agent and its Re analog [186Re]Re-HEDP is now well established as a therapeutic radiopharmaceutical for palliation of pain due to bone metastases. In the present paper, we report the work carried out for the preparation of stable 186Re-HEDP which retains RC purity up to 5 days when stored at 4 deg. C. 186Re was prepared by irradiation of natural Re metal at a flux of 3x1013 neutrons/cm2/s for seven days and processed after a cooling period of four days. The specific activity of 186Re formed was ∼35 mCi/mg. A complex with RC purity >98% could be prepared by varying the reaction conditions. By carefully optimizing the reaction and storage conditions, a complex which was stable for over 4 days could be synthesized. Bio-distribution studies carried out in rats revealed ∼30% bone uptake of 186Re-HEDP at 3 h postinjection which remained almost constant for 48 h, at which time there was negligible activity in other organs